SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and seasonal influenza viruses are cocirculating in the human population. However, only a few cases of viral coinfection with these two viruses have been documented in humans with some people having severe disease and others mild disease....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of virology 2022-03, Vol.96 (5), p.e0179121-e0179121
Hauptverfasser: Huang, Ying, Skarlupka, Amanda L, Jang, Hyesun, Blas-Machado, Uriel, Holladay, Nathan, Hogan, R Jeffrey, Ross, Ted M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e0179121
container_issue 5
container_start_page e0179121
container_title Journal of virology
container_volume 96
creator Huang, Ying
Skarlupka, Amanda L
Jang, Hyesun
Blas-Machado, Uriel
Holladay, Nathan
Hogan, R Jeffrey
Ross, Ted M
description Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and seasonal influenza viruses are cocirculating in the human population. However, only a few cases of viral coinfection with these two viruses have been documented in humans with some people having severe disease and others mild disease. To examine this phenomenon, ferrets were coinfected with SARS-CoV-2 and human seasonal influenza A viruses (IAVs; H1N1 or H3N2) and were compared to animals that received each virus alone. Ferrets were either immunologically naive to both viruses or vaccinated with the 2019 to 2020 split-inactivated influenza virus vaccine. Coinfected naive ferrets lost significantly more body weight than ferrets infected with each virus alone and had more severe inflammation in both the nose and lungs compared to that of ferrets that were single infected with each virus. Coinfected, naive animals had predominantly higher IAV titers than SARS-CoV-2 titers, and IAVs were efficiently transmitted by direct contact to the cohoused ferrets. Comparatively, SARS-CoV-2 failed to transmit to the ferrets that cohoused with coinfected ferrets by direct contact. Moreover, vaccination significantly reduced IAV titers and shortened the viral shedding but did not completely block direct contact transmission of the influenza virus. Notably, vaccination significantly ameliorated influenza-associated disease by protecting vaccinated animals from severe morbidity after IAV single infection or IAV and SARS-CoV-2 coinfection, suggesting that seasonal influenza virus vaccination is pivotal to prevent severe disease induced by IAV and SARS-CoV-2 coinfection during the COVID-19 pandemic. Influenza A viruses cause severe morbidity and mortality during each influenza virus season. The emergence of SARS-CoV-2 infection in the human population offers the opportunity to potential coinfections of both viruses. The development of useful animal models to assess the pathogenesis, transmission, and viral evolution of these viruses as they coinfect a host is of critical importance for the development of vaccines and therapeutics. The ability to prevent the most severe effects of viral coinfections can be studied using effect coinfection ferret models described in this report.
doi_str_mv 10.1128/jvi.01791-21
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8906421</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2613295177</sourcerecordid><originalsourceid>FETCH-LOGICAL-a418t-cd0548379ef6f0bb642447a58b5499065d83229259a4e9ac246ab886240d6ae53</originalsourceid><addsrcrecordid>eNp1kUFLwzAYQIMobk5vnqVHBTuTNEmTizCKU2EgOB3eQtqmmtElM2kH-uut2xx68PQd8njhex8ApwgOEcL8ar4yQ4hSgWKM9kAfQcFjShHZB30IMY5pwl964CiEOYSIEEYOQS8hImGEp33Ap6PHaZy5WYwjZcvo3lZ1q-2nikbRzPg2RJkzttJFY5wNkbHRWHuvm3AMDipVB32ynQPwPL55yu7iycPtfTaaxIog3sRFCSnhSSp0xSqY54xgQlJFeU6JEJDRkicYC0yFIlqoAhOmcs4ZJrBkStNkAK433mWbL3RZaNt4VculNwvlP6RTRv59seZNvrqV5J2dYNQJzrcC795bHRq5MKHQda2sdm2QmKEEC4rStEMvN2jhXQheV7tvEJTfsWUXW65jy7X5YoOrsMBy7lpvuxL_sWe_19iJfy6RfAHcOYXn</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2613295177</pqid></control><display><type>article</type><title>SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Huang, Ying ; Skarlupka, Amanda L ; Jang, Hyesun ; Blas-Machado, Uriel ; Holladay, Nathan ; Hogan, R Jeffrey ; Ross, Ted M</creator><contributor>Parrish, Colin R ; Parrish, Colin R.</contributor><creatorcontrib>Huang, Ying ; Skarlupka, Amanda L ; Jang, Hyesun ; Blas-Machado, Uriel ; Holladay, Nathan ; Hogan, R Jeffrey ; Ross, Ted M ; Parrish, Colin R ; Parrish, Colin R.</creatorcontrib><description>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and seasonal influenza viruses are cocirculating in the human population. However, only a few cases of viral coinfection with these two viruses have been documented in humans with some people having severe disease and others mild disease. To examine this phenomenon, ferrets were coinfected with SARS-CoV-2 and human seasonal influenza A viruses (IAVs; H1N1 or H3N2) and were compared to animals that received each virus alone. Ferrets were either immunologically naive to both viruses or vaccinated with the 2019 to 2020 split-inactivated influenza virus vaccine. Coinfected naive ferrets lost significantly more body weight than ferrets infected with each virus alone and had more severe inflammation in both the nose and lungs compared to that of ferrets that were single infected with each virus. Coinfected, naive animals had predominantly higher IAV titers than SARS-CoV-2 titers, and IAVs were efficiently transmitted by direct contact to the cohoused ferrets. Comparatively, SARS-CoV-2 failed to transmit to the ferrets that cohoused with coinfected ferrets by direct contact. Moreover, vaccination significantly reduced IAV titers and shortened the viral shedding but did not completely block direct contact transmission of the influenza virus. Notably, vaccination significantly ameliorated influenza-associated disease by protecting vaccinated animals from severe morbidity after IAV single infection or IAV and SARS-CoV-2 coinfection, suggesting that seasonal influenza virus vaccination is pivotal to prevent severe disease induced by IAV and SARS-CoV-2 coinfection during the COVID-19 pandemic. Influenza A viruses cause severe morbidity and mortality during each influenza virus season. The emergence of SARS-CoV-2 infection in the human population offers the opportunity to potential coinfections of both viruses. The development of useful animal models to assess the pathogenesis, transmission, and viral evolution of these viruses as they coinfect a host is of critical importance for the development of vaccines and therapeutics. The ability to prevent the most severe effects of viral coinfections can be studied using effect coinfection ferret models described in this report.</description><identifier>ISSN: 0022-538X</identifier><identifier>EISSN: 1098-5514</identifier><identifier>DOI: 10.1128/jvi.01791-21</identifier><identifier>PMID: 34936487</identifier><language>eng</language><publisher>United States: American Society for Microbiology</publisher><subject>Animals ; Antibodies, Viral - blood ; Coinfection - prevention &amp; control ; COVID-19 - immunology ; COVID-19 - prevention &amp; control ; Female ; Ferrets - immunology ; Immunology ; Influenza A Virus, H1N1 Subtype - genetics ; Influenza A Virus, H1N1 Subtype - immunology ; Influenza A Virus, H3N2 Subtype - genetics ; Influenza A Virus, H3N2 Subtype - immunology ; Influenza Vaccines - immunology ; Orthomyxoviridae Infections - immunology ; Orthomyxoviridae Infections - prevention &amp; control ; Spotlight ; Spotlight Selection ; Vaccination ; Vaccines and Antiviral Agents ; Virus Shedding</subject><ispartof>Journal of virology, 2022-03, Vol.96 (5), p.e0179121-e0179121</ispartof><rights>Copyright © 2022 American Society for Microbiology.</rights><rights>Copyright © 2022 American Society for Microbiology. 2022 American Society for Microbiology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a418t-cd0548379ef6f0bb642447a58b5499065d83229259a4e9ac246ab886240d6ae53</citedby><cites>FETCH-LOGICAL-a418t-cd0548379ef6f0bb642447a58b5499065d83229259a4e9ac246ab886240d6ae53</cites><orcidid>0000-0003-1947-7469</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906421/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906421/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,728,781,785,886,27929,27930,53796,53798</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34936487$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Parrish, Colin R</contributor><contributor>Parrish, Colin R.</contributor><creatorcontrib>Huang, Ying</creatorcontrib><creatorcontrib>Skarlupka, Amanda L</creatorcontrib><creatorcontrib>Jang, Hyesun</creatorcontrib><creatorcontrib>Blas-Machado, Uriel</creatorcontrib><creatorcontrib>Holladay, Nathan</creatorcontrib><creatorcontrib>Hogan, R Jeffrey</creatorcontrib><creatorcontrib>Ross, Ted M</creatorcontrib><title>SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets</title><title>Journal of virology</title><addtitle>J Virol</addtitle><addtitle>J Virol</addtitle><description>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and seasonal influenza viruses are cocirculating in the human population. However, only a few cases of viral coinfection with these two viruses have been documented in humans with some people having severe disease and others mild disease. To examine this phenomenon, ferrets were coinfected with SARS-CoV-2 and human seasonal influenza A viruses (IAVs; H1N1 or H3N2) and were compared to animals that received each virus alone. Ferrets were either immunologically naive to both viruses or vaccinated with the 2019 to 2020 split-inactivated influenza virus vaccine. Coinfected naive ferrets lost significantly more body weight than ferrets infected with each virus alone and had more severe inflammation in both the nose and lungs compared to that of ferrets that were single infected with each virus. Coinfected, naive animals had predominantly higher IAV titers than SARS-CoV-2 titers, and IAVs were efficiently transmitted by direct contact to the cohoused ferrets. Comparatively, SARS-CoV-2 failed to transmit to the ferrets that cohoused with coinfected ferrets by direct contact. Moreover, vaccination significantly reduced IAV titers and shortened the viral shedding but did not completely block direct contact transmission of the influenza virus. Notably, vaccination significantly ameliorated influenza-associated disease by protecting vaccinated animals from severe morbidity after IAV single infection or IAV and SARS-CoV-2 coinfection, suggesting that seasonal influenza virus vaccination is pivotal to prevent severe disease induced by IAV and SARS-CoV-2 coinfection during the COVID-19 pandemic. Influenza A viruses cause severe morbidity and mortality during each influenza virus season. The emergence of SARS-CoV-2 infection in the human population offers the opportunity to potential coinfections of both viruses. The development of useful animal models to assess the pathogenesis, transmission, and viral evolution of these viruses as they coinfect a host is of critical importance for the development of vaccines and therapeutics. The ability to prevent the most severe effects of viral coinfections can be studied using effect coinfection ferret models described in this report.</description><subject>Animals</subject><subject>Antibodies, Viral - blood</subject><subject>Coinfection - prevention &amp; control</subject><subject>COVID-19 - immunology</subject><subject>COVID-19 - prevention &amp; control</subject><subject>Female</subject><subject>Ferrets - immunology</subject><subject>Immunology</subject><subject>Influenza A Virus, H1N1 Subtype - genetics</subject><subject>Influenza A Virus, H1N1 Subtype - immunology</subject><subject>Influenza A Virus, H3N2 Subtype - genetics</subject><subject>Influenza A Virus, H3N2 Subtype - immunology</subject><subject>Influenza Vaccines - immunology</subject><subject>Orthomyxoviridae Infections - immunology</subject><subject>Orthomyxoviridae Infections - prevention &amp; control</subject><subject>Spotlight</subject><subject>Spotlight Selection</subject><subject>Vaccination</subject><subject>Vaccines and Antiviral Agents</subject><subject>Virus Shedding</subject><issn>0022-538X</issn><issn>1098-5514</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kUFLwzAYQIMobk5vnqVHBTuTNEmTizCKU2EgOB3eQtqmmtElM2kH-uut2xx68PQd8njhex8ApwgOEcL8ar4yQ4hSgWKM9kAfQcFjShHZB30IMY5pwl964CiEOYSIEEYOQS8hImGEp33Ap6PHaZy5WYwjZcvo3lZ1q-2nikbRzPg2RJkzttJFY5wNkbHRWHuvm3AMDipVB32ynQPwPL55yu7iycPtfTaaxIog3sRFCSnhSSp0xSqY54xgQlJFeU6JEJDRkicYC0yFIlqoAhOmcs4ZJrBkStNkAK433mWbL3RZaNt4VculNwvlP6RTRv59seZNvrqV5J2dYNQJzrcC795bHRq5MKHQda2sdm2QmKEEC4rStEMvN2jhXQheV7tvEJTfsWUXW65jy7X5YoOrsMBy7lpvuxL_sWe_19iJfy6RfAHcOYXn</recordid><startdate>20220309</startdate><enddate>20220309</enddate><creator>Huang, Ying</creator><creator>Skarlupka, Amanda L</creator><creator>Jang, Hyesun</creator><creator>Blas-Machado, Uriel</creator><creator>Holladay, Nathan</creator><creator>Hogan, R Jeffrey</creator><creator>Ross, Ted M</creator><general>American Society for Microbiology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-1947-7469</orcidid></search><sort><creationdate>20220309</creationdate><title>SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets</title><author>Huang, Ying ; Skarlupka, Amanda L ; Jang, Hyesun ; Blas-Machado, Uriel ; Holladay, Nathan ; Hogan, R Jeffrey ; Ross, Ted M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a418t-cd0548379ef6f0bb642447a58b5499065d83229259a4e9ac246ab886240d6ae53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Animals</topic><topic>Antibodies, Viral - blood</topic><topic>Coinfection - prevention &amp; control</topic><topic>COVID-19 - immunology</topic><topic>COVID-19 - prevention &amp; control</topic><topic>Female</topic><topic>Ferrets - immunology</topic><topic>Immunology</topic><topic>Influenza A Virus, H1N1 Subtype - genetics</topic><topic>Influenza A Virus, H1N1 Subtype - immunology</topic><topic>Influenza A Virus, H3N2 Subtype - genetics</topic><topic>Influenza A Virus, H3N2 Subtype - immunology</topic><topic>Influenza Vaccines - immunology</topic><topic>Orthomyxoviridae Infections - immunology</topic><topic>Orthomyxoviridae Infections - prevention &amp; control</topic><topic>Spotlight</topic><topic>Spotlight Selection</topic><topic>Vaccination</topic><topic>Vaccines and Antiviral Agents</topic><topic>Virus Shedding</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Huang, Ying</creatorcontrib><creatorcontrib>Skarlupka, Amanda L</creatorcontrib><creatorcontrib>Jang, Hyesun</creatorcontrib><creatorcontrib>Blas-Machado, Uriel</creatorcontrib><creatorcontrib>Holladay, Nathan</creatorcontrib><creatorcontrib>Hogan, R Jeffrey</creatorcontrib><creatorcontrib>Ross, Ted M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of virology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Huang, Ying</au><au>Skarlupka, Amanda L</au><au>Jang, Hyesun</au><au>Blas-Machado, Uriel</au><au>Holladay, Nathan</au><au>Hogan, R Jeffrey</au><au>Ross, Ted M</au><au>Parrish, Colin R</au><au>Parrish, Colin R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets</atitle><jtitle>Journal of virology</jtitle><stitle>J Virol</stitle><addtitle>J Virol</addtitle><date>2022-03-09</date><risdate>2022</risdate><volume>96</volume><issue>5</issue><spage>e0179121</spage><epage>e0179121</epage><pages>e0179121-e0179121</pages><issn>0022-538X</issn><eissn>1098-5514</eissn><abstract>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and seasonal influenza viruses are cocirculating in the human population. However, only a few cases of viral coinfection with these two viruses have been documented in humans with some people having severe disease and others mild disease. To examine this phenomenon, ferrets were coinfected with SARS-CoV-2 and human seasonal influenza A viruses (IAVs; H1N1 or H3N2) and were compared to animals that received each virus alone. Ferrets were either immunologically naive to both viruses or vaccinated with the 2019 to 2020 split-inactivated influenza virus vaccine. Coinfected naive ferrets lost significantly more body weight than ferrets infected with each virus alone and had more severe inflammation in both the nose and lungs compared to that of ferrets that were single infected with each virus. Coinfected, naive animals had predominantly higher IAV titers than SARS-CoV-2 titers, and IAVs were efficiently transmitted by direct contact to the cohoused ferrets. Comparatively, SARS-CoV-2 failed to transmit to the ferrets that cohoused with coinfected ferrets by direct contact. Moreover, vaccination significantly reduced IAV titers and shortened the viral shedding but did not completely block direct contact transmission of the influenza virus. Notably, vaccination significantly ameliorated influenza-associated disease by protecting vaccinated animals from severe morbidity after IAV single infection or IAV and SARS-CoV-2 coinfection, suggesting that seasonal influenza virus vaccination is pivotal to prevent severe disease induced by IAV and SARS-CoV-2 coinfection during the COVID-19 pandemic. Influenza A viruses cause severe morbidity and mortality during each influenza virus season. The emergence of SARS-CoV-2 infection in the human population offers the opportunity to potential coinfections of both viruses. The development of useful animal models to assess the pathogenesis, transmission, and viral evolution of these viruses as they coinfect a host is of critical importance for the development of vaccines and therapeutics. The ability to prevent the most severe effects of viral coinfections can be studied using effect coinfection ferret models described in this report.</abstract><cop>United States</cop><pub>American Society for Microbiology</pub><pmid>34936487</pmid><doi>10.1128/jvi.01791-21</doi><tpages>15</tpages><orcidid>https://orcid.org/0000-0003-1947-7469</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-538X
ispartof Journal of virology, 2022-03, Vol.96 (5), p.e0179121-e0179121
issn 0022-538X
1098-5514
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8906421
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Animals
Antibodies, Viral - blood
Coinfection - prevention & control
COVID-19 - immunology
COVID-19 - prevention & control
Female
Ferrets - immunology
Immunology
Influenza A Virus, H1N1 Subtype - genetics
Influenza A Virus, H1N1 Subtype - immunology
Influenza A Virus, H3N2 Subtype - genetics
Influenza A Virus, H3N2 Subtype - immunology
Influenza Vaccines - immunology
Orthomyxoviridae Infections - immunology
Orthomyxoviridae Infections - prevention & control
Spotlight
Spotlight Selection
Vaccination
Vaccines and Antiviral Agents
Virus Shedding
title SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-11T08%3A37%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=SARS-CoV-2%20and%20Influenza%20A%20Virus%20Coinfections%20in%20Ferrets&rft.jtitle=Journal%20of%20virology&rft.au=Huang,%20Ying&rft.date=2022-03-09&rft.volume=96&rft.issue=5&rft.spage=e0179121&rft.epage=e0179121&rft.pages=e0179121-e0179121&rft.issn=0022-538X&rft.eissn=1098-5514&rft_id=info:doi/10.1128/jvi.01791-21&rft_dat=%3Cproquest_pubme%3E2613295177%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2613295177&rft_id=info:pmid/34936487&rfr_iscdi=true